Elevara Medicines

London, England, United Kingdom · Biotechnology, Health Care · 13 employees

Elevara Medicines is a clinical-stage biotech company focused on developing therapies for rheumatoid arthritis (RA) and chronic inflammatory diseases. The company's lead program, ELV001, is an innovative oral CDK4/6 inhibitor that targets synovial fibroblasts, aiming to disrupt traditional treatment paradigms. Elevara's goal is to provide effective options for patients who do not achieve disease r

See plans & pricing → Track Elevara Medicines’s funding, hiring, and signals — with verified contacts — on Fundz.